Transenterix Inc Corporate Analyst Meeting Transcript
Good morning, and thank you for joining us. Our goal for today is to share our vision for the future of surgery and how we plan to deliver on that vision.
Up to this point, you have known us as a robotics company. However, we believe that robotics as a stand-alone technology has limited application over the long term. Robotic-assisted surgery has been around for decades, but adoption is still low. What that tells us is that patients, surgeons and hospitals need more than a robot.
We believe that the future of surgery will bring machine vision, augmented intelligence and deep learning capabilities throughout the surgical experience. The future of surgery is the evolution from robotic-assisted surgery to digital surgery, and we intend to deliver on this future.
Before we dive into the future, I want to quickly walk through our journey. Over a relatively short period of time, we have made tremendous progress as a company. In late 2017, we became the first soft tissue abdominal robotic platform to get FDA
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |